CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The new online Learning Center with new content can still be found under the “Training” folder on ...